Clinical trial

Effect of Salicylate on Glucose Metabolism in Insulin Resistance States

NCT00258128 · Joslin Diabetes Center, Other · Completed

Key facts

NCT number NCT00258128
Title Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
Official title Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
Lead sponsor Joslin Diabetes Center, Other
Collaborators National Institutes of Health (NIH) NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Insulin Resistance
Intervention type Drug
Interventions Salsalate, Placebo
Enrollment 17
Start date Jan 1, 2000
Primary completion May 1, 2008
Completion May 1, 2008
First posted Nov 24, 2005
Last update posted Apr 30, 2019

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies